Christopher Ogden - Chief Financial Officer at CytomX Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
CTMX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Christopher Ogden - trading volume in the past year for CytomX Therapeutics, Inc.

Holdings reported by Christopher Ogden for CytomX Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 226K $608K $2.69 Jun 16, 2025 Direct
Performance Stock Units (PSUs) 39.2K $0 $1.23 Sep 26, 2025 Direct Common Stock
Stock Option (Right to Buy) 78.3K Sep 26, 2025 Direct Common Stock
Performance Stock Units 0 Jun 13, 2025 Direct Common Stock

Transactions reported by Christopher Ogden for CytomX Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.